✦ LIBER ✦

Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer

✍ Scribed by Delord, J-P; Bennouna, J; Artru, P; Perrier, H; Husseini, F; Desseigne, F; François, E; Faroux, R; Smith, D; Piedbois, P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of weekly irinotecan as

✍ Hideki Ueno; Takuji Okusaka; Akihiro Funakoshi; Hiroshi Ishii; Kenji Yamao; Osam 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 328 KB

Phase II study of oxaliplatin, UFT, and

✍ Ester J. M. Siemerink; Annemieke F. J. Drenth; Nanno H. Mulder; John T. M. Plukk 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 245 KB

Phase I/II study of sequential therapy w

✍ Yoshioka, T; Kato, S; Gamoh, M; Chiba, N; Suzuki, T; Sakayori, N; Kato, S; Shiba 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 257 KB

A multicenter phase II study of irinotec

✍ JuanJosé Reina; Jorge Aparicio; Javier Salvador; JoséMaríaPuerto Pica; Antonio R 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 192 KB

‘A phase II study of oral uracil/ftorafu

✍ Bennouna, J; Perrier, H; Paillot, B; Priou, F; Jacob, J H; Hebbar, M; Bordenave, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

Phase I study of gefitinib, irinotecan,

✍ Jeffrey A. Meyerhardt; Jeffrey W. Clark; Jeffrey G. Supko; Joseph P. Eder; Shuji 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 329 KB